(firstQuint)AMG 986 20150186 Renal Impairment Study.

 This is a multisite (approximately 3 sites), open-label, non-randomized, single-dose study in subjects with severely impaired kidney function and healthy subjects.

 About 12 subjects will be assigned to two groups: Group 1: 6 with severely impaired kidney function , and Group 2: 6 subjects with normal kidney function.

.

 AMG 986 20150186 Renal Impairment Study@highlight

A study to assess the safety, tolerability, and pharmacokinetics of AMG 986 given orally as a single dose to healthy subjects and subjects with severely impaired kidney function.

